BrightSpring Health Services, Inc. Common Stock (BTSG)vsMangoceuticals, Inc. Common Stock (MGRX)
BTSG
BrightSpring Health Services, Inc. Common Stock
$44.82
+3.49%
HEALTHCARE · Cap: $8.32B
MGRX
Mangoceuticals, Inc. Common Stock
$0.33
+8.31%
HEALTHCARE · Cap: $5.27M
Smart Verdict
WallStSmart Research — data-driven comparison
BrightSpring Health Services, Inc. Common Stock generates 2765008% more annual revenue ($12.91B vs $466,910). BTSG leads profitability with a 1.5% profit margin vs 0.0%. BTSG earns a higher WallStSmart Score of 54/100 (C-).
BTSG
Buy54
out of 100
Grade: C-
MGRX
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-78.4%
Fair Value
$22.46
Current Price
$44.82
$22.36 premium
Intrinsic value data unavailable for MGRX.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 29.3% year-over-year
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
3.4% earnings growth
ROE of 5.9% — below average capital efficiency
1.5% margin — thin
Operating margin of 3.0%
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : BTSG
The strongest argument for BTSG centers on Revenue Growth. Revenue growth of 29.3% demonstrates continued momentum.
Bull Case : MGRX
The strongest argument for MGRX centers on Price/Book, Debt/Equity.
Bear Case : BTSG
The primary concerns for BTSG are EPS Growth, Return on Equity, Profit Margin. A P/E of 90.2x leaves little room for execution misses. Thin 1.5% margins leave little buffer for downturns.
Bear Case : MGRX
The primary concerns for MGRX are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
BTSG profiles as a growth stock while MGRX is a value play — different risk/reward profiles.
MGRX carries more volatility with a beta of 2.33 — expect wider price swings.
BTSG is growing revenue faster at 29.3% — sustainability is the question.
BTSG generates stronger free cash flow (174M), providing more financial flexibility.
Bottom Line
BTSG scores higher overall (54/100 vs 24/100) and 29.3% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BrightSpring Health Services, Inc. Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, specializing in meeting the intricate needs of a diverse patient population, including individuals with intellectual and developmental disabilities as well as those requiring rehabilitation. The company emphasizes personalized care solutions backed by a highly trained workforce, ensuring exceptional patient outcomes. BrightSpring's strategic investment in technology and commitment to quality enable it to thrive in the growing market for value-based care, making it well-positioned to capitalize on the ongoing evolution of the healthcare landscape.
Visit Website →Mangoceuticals, Inc. Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Mangoceuticals, Inc. focuses to develop, market, and sell various men's wellness products and services through a telemedicine platform. The company is headquartered in Dallas, Texas.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?